Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: A stepped-wedge evaluation

AIDS

Volumn 24, Issue 1, 2010, Pages 85-91

  Killam, William P ^a,b   Tambatamba, Bushimbwa C ^c   Chintu, Namwinga ^b   Rouse, Dwight ^a   Stringer, Elizabeth ^a,b   Bweupe, Maximillian ^c   Yu, Yong ^a,b   Stringer, Jeffrey Sa ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Centre for Infectious Disease Research   (Zambia)

^c MINISTRY OF HEALTH   (Zambia)

Author keywords

Antiretroviral treatment; ART; HIV; Mother to child transmission; Pregnancy; Resource limited countries

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COTRIMOXAZOLE;

ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; ZAMBIA;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PRIMARY HEALTH CARE; ZAMBIA;

EID: 73649094434     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833298be     Document Type: Article

References (22)

1. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings: towards universal access. Geneva: WHO; 2006.
2. U. S. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission to reduce perinatal HIV-1 transmission in the United States. Updated June 23, 2004. http://www.aidsinfo. nih.gov/guidelines/perinatal/PER-062304.pdf. [Accessed 10 December 2004].
3. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002; 29:484-494.
4. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000; 283:1175-1182. (Pubitemid 30126606)
5. Colebunders R, Kolsteren P, Ryder R. Giving antiretrovirals in the peripartum period to prevent mother-to-child HIV transmission in low-income countries: only a short-term stopgap measure [editorial]. Trop Med Int Health 2003; 8:375-377.
6. Maclean CC, Stringer JS. Potential cost-effectiveness of maternal and infant antiretroviral interventions to prevent mother-to-child transmission during breast-feeding. J Acquir Immune Defic Syndr 2005; 38:570-577.
7. Black V, Hoffman RM, Sugar CA, Menon P, Venter F, Currier JS, et al. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2008; 49:276-281.
8. van der Merwe K, Chersich MF, Technau K, Umurungi Y, Conradie F, Coovadia A. Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa. J Acquir Immune Defic Syndr 2006; 43:577-581.
9. Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med Res Methodol 2006; 6:54.
10. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 2007; 28:182-191.
11. Ministry of Health Zambia. National Protocol Guidelines for Integrated Prevention of Mother-to-Child Transmission of HIV/ AIDS. Vol.53. Printec Press; 2007.
12. Kelley C. The ZEPRS Project. In Cressman G, editor. Raleigh, NC, USA: Research Triangle Institute; 2006. [this Web site provides documentation about the ZEPRS project and system]
13. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006; 296:782-793.
14. Hughes JP, Goldenberg RL, Wilfert CM, Valentine M, Kasonde G, Guay LA, et al. Design of the HIV Prevention Trials Network (HPTN) Protocol 054: A cluster randomized crossover trial to evaluate combined access to nevirapine in developing countries. UW Biostatistics Working Paper Series. Seattle, WA: University of Washington; 2003. p. 15.
15. Patel D, Cortina-Borja M, Thorne C, Newell ML. Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis 2007; 44:1647-1656.
16. Watts DH, Balasubramanian R, Maupin RT Jr, Delke I, Dor-enbaum A, Fiore S, et al. Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316. Am J Obstet Gynecol 2004; 190:506-516.
17. Marazzi CM, Germano P, Liotta G, Guidotti G, Loureiro S, Gomes Ada C, et al. Implementing antiretroviral triple therapy to prevent HIV mother-to-child transmission: a public health approach in resource-limited settings. Eur J Pediatr 2007; 166:1305-1307.
18. Luzuriaga K, Sullivan JL. Prevention of mother-to-child transmission of HIV infection. Clin Infect Dis 2005; 40:466-467.
19. Painter TM, Diaby KL, Matia DM, Lin LS, Sibailly TS, Kouassi MK, et al. Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study. BMJ 2004; 329:543.
20. Chi BH, Chansa K, Gardner MO, Sangi-Haghpeykar H, Gold-enberg RL, Sinkala M, et al. Perceptions toward HIV, HIV screening, and the use of antiretroviral medications: a survey of maternity-based healthcare providers in Zambia. Int J STD AIDS 2004; 15:685-690.
21. Chi BH, Fusco H, Sinkala M, Goldenberg RL, Stringer JS. Cost and enrollment implications of targeting different source population for an HIV treatment program. J Acquir Immune Defic Syndr 2005; 40:350-355.
22. Chi BH, Sinkala M, Stringer EM, McFarlane Y, Ng'uni C, Myzece E, et al. Employment of off-duty staff: a strategy to meet the human resource needs for a large PMTCT program in Zambia. J Acquir Immune Defic Syndr 2005; 40:381-382.